Last reviewed · How we verify

iron sucrose injection USP — Competitive Intelligence Brief

iron sucrose injection USP (iron sucrose injection USP) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Iron replacement agent. Area: Hematology.

phase 3 Iron replacement agent Iron (Fe3+) delivery; transferrin receptor-mediated uptake Hematology Small molecule Live · refreshed every 30 min

Target snapshot

iron sucrose injection USP (iron sucrose injection USP) — American Regent, Inc.. Iron sucrose delivers iron directly into the bloodstream as a stable complex to replenish iron stores and support hemoglobin synthesis in patients with iron deficiency.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
iron sucrose injection USP TARGET iron sucrose injection USP American Regent, Inc. phase 3 Iron replacement agent Iron (Fe3+) delivery; transferrin receptor-mediated uptake
i.v. iron sucrose i.v. iron sucrose J. Uriach and Company marketed Iron replacement agent
Venofer® Venofer® Azad Pharma AG marketed Iron replacement agent
High-dose ferric derisomaltose High-dose ferric derisomaltose China-Japan Friendship Hospital marketed Iron replacement agent
Sodium ferric gluconate Sodium ferric gluconate University of North Carolina, Chapel Hill marketed Iron replacement agent Iron (Fe3+) delivery system
Iron Carboxymaltose Iron Carboxymaltose Albina Nowak, MD marketed Intravenous iron replacement agent Iron(III) ion; transferrin and ferritin (iron-binding proteins)
Ferric Carboxymaltose Injection Ferric Carboxymaltose Injection Sichuan Huiyu Pharmaceutical Co., Ltd marketed Iron replacement agent Iron metabolism pathway; transferrin receptor

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Iron replacement agent class)

  1. University of Maryland, Baltimore · 2 drugs in this class
  2. Ain Shams University · 1 drug in this class
  3. American Regent, Inc. · 1 drug in this class
  4. Azad Pharma AG · 1 drug in this class
  5. CN NGANOU-GNINDJIO, MD, MSc · 1 drug in this class
  6. China-Japan Friendship Hospital · 1 drug in this class
  7. Hallym University Medical Center · 1 drug in this class
  8. J. Uriach and Company · 1 drug in this class
  9. JW Pharmaceutical · 1 drug in this class
  10. Prince of Wales Hospital, Shatin, Hong Kong · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). iron sucrose injection USP — Competitive Intelligence Brief. https://druglandscape.com/ci/iron-sucrose-injection-usp. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators: